Effects of Adenovirus E1A Protein on Interferon-Signaling  by Leonard, George T. & Sen, Ganes C.
VIROLOGY 224, 25 –33 (1996)
ARTICLE NO. 0503
Effects of Adenovirus E1A Protein on Interferon-Signaling
GEORGE T. LEONARD and GANES C. SEN1
Department of Molecular Biology, The Cleveland Clinic Foundation, Research Institute, 9500 Euclid Avenue, Cleveland, Ohio 44195;
and Graduate Program in Biochemistry, Case Western Reserve University, 19500 Euclid Avenue, Cleveland, Ohio 44106
Received March 5, 1996; accepted July 25, 1996
We have previously shown that adenovirus E1A proteins can block interferon-a (IFN-a)-signaling. In the current study,
we examined if the same is true for IFN-g signaling. Cotransfection experiments showed that both 289R and 243R forms
of E1A could block the expression of an IFN-g-inducible reporter gene. Similarly, in an E1A-expressing HeLa cell line IFN-
g failed to induce the synthesis of IRF-1 mRNA. This failure was due to a block in activation of the crucial trans-acting
factor, GAF, which in turn was due to the lack of IFN-g-activated tyrosine phosphorylation of the STAT1a protein in E1A-
expressing cells. The above defect could be attributed to a reduced level of STAT1a protein. The level of p48 protein, which
is required for IFN-a signaling, was also lowered. However, the level of Jak-1 protein, one of the tyrosine kinases necessary
for both IFN-a and IFN-g signaling, was comparable in the E1A-expressing and the control cells. These results indicate
that the observed inhibition of IFN signaling in E1A-expressing cells is a consequence of a lower abundance of the necessary
trans-acting factors. q 1996 Academic Press, Inc.
INTRODUCTION transducers and activators of transcription, STAT1a and
STAT2 (Darnell et al., 1994; Ihle, 1996). The ISGF3 com-
Adenoviruses are able to escape the antiviral proper-
plex binds to the interferon-stimulated response element
ties of interferon as well as confer susceptibility to sec-
(ISRE) and activates transcription of many IFN-a-induc-ondary virus infection upon the cells that they infect (An-
ible genes (Stark and Kerr, 1992). IFN-g can induce tran-derson and Fennie, 1987; Kalvakolanu et al., 1991). A
scription of genes through many different cis elements.great portion of the adenovirus recalcitrance to interferon
The gamma-activated sequence (GAS) is found in theis mediated through the adenovirus E1A proteins (Ander-
regulatory regions of the high-affinity IgG receptor geneson and Fennie, 1987; Kalvakolanu et al., 1991; Ackrill et
(Pearse et al., 1991), the interferon regulatory factor-1al., 1991; Gutch and Reich, 1991). The E1A proteins are
(IRF-1) gene (Sims et al., 1993), and the Ly-6A/E geneamong the first of the adenovirus proteins expressed in
(Khan et al., 1993). The ISRE of the 9-27 gene (Reid etinfected cells. Through alternative splicing two major E1A
al., 1989) is necessary for induction by IFN-g, while bothspecies are produced, a 243-residue protein and a 289-
the ISRE and the GAS in the guanylate-binding proteinresidue protein. These two predominant E1A proteins
promoter are needed for maximal induction by IFN-gdiffer in a 46-residue domain exclusive to the larger pro-
(Lew et al., 1991). IFN-g also induces transcription in atein (Moran and Mathews, 1987). The adenoviral E1A
protein synthesis-dependent manner through the poorlyproteins are potent regulators of gene expression and
understood cis-elements of the MHC Class II gene pro-cell function (Nevins, 1995). E1A can function as a repres-
moter (Steimle et al., 1994; Yang et al., 1990). The mecha-sor of enhanced transcription (Datta and Bagchi, 1994;
nism of gene activation through the GAS element by IFN-Dorsman et al., 1995; Kalvakolanu et al., 1991; Nakamura
g is the most well-understood (Shuai et al., 1992). IFN-g,et al., 1992), as a transcriptional activator (Moran et al.,
upon binding a two subunit cell surface receptor, initiates1986), and as a modulator of cell growth, differentiation,
tyrosine phosphorylation of a variety of proteins includingand transformation (Moran and Mathews, 1987; Mymryk
the receptor subunits, two tyrosine kinases of the Januset al., 1992; Shenk and Flint, 1991; Wang et al., 1993).
kinase family, Jak1 and Jak2; and the DNA-bindingThe interferons possess potent antiviral activities me-
protein STAT1a. Activated (tyrosine-phosphorylated)diated through the products of the interferon-inducible
STAT1a dimerizes through interactions between the SH2genes (Sen and Ransohoff, 1993). Interferon-a (IFN-a)
regions of the protein and the phosphorylated tyrosines.activates a trans-acting factor, the interferon-stimulated
The homodimers translocate to the nucleus and bind asgene factor 3 (ISGF3), that consists of a DNA-binding
part of a complex, the gamma-activated factor (GAF), tosubunit, p48, and at least two other factors, the signal
the GAS DNA element. The GAS element is both neces-
sary and sufficient to confer transcriptional activation of1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (216) 444-0512. the IRF-1 gene by IFN-g (Sims et al., 1993).
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In this report we have examined the effects of adenovi- was removed and the cells were washed with 11 PBS.
The cells were then shocked with 15% DMSO in serum-ral E1A proteins on IFN-g-induced gene transcription us-
ing IRF-1 as a test gene. The cotransfection of E1A ex- free DMEM for 2 min. At 25 hr posttransfection the cells
were treated with either IFN-g (500 U/ml) or left un-pression constructs with reporter constructs driven by
the IRF-1 regulatory elements shows that E1A can down- treated. At 43 hr posttransfection the cells were har-
vested and extracts prepared in Reporter Lysis Bufferregulate the induction of these reporter genes by IFN-g.
For analyzing E1A’s effects on components of the IFN- (Cat. No. E3971, Promega, Madison, WI) according to
manufacturer’s suggestion. Luciferase assay was alsog signal transduction pathway we have used an E1A-
expressing cell line, HeLa-E1A (Kalvakolanu et al., 1991). performed according to Promega and Relative Light Units
were quantitated with a luminometer (Dynatech, modelGAF activation fails to occur in HeLa-E1A cells in re-
sponse to IFN-g. This defect is presumably due to lack ML2250). The CAT assays were performed as described
previously (Goraya et al., 1994) using equal amounts ofof sufficient levels of functional STAT1a in HeLa-E1A
cells. protein from each transfectant. Extracts were incubated
for 1 hr at 377. The samples were extracted with 1 ml of
ethyl acetate, the organic phase collected, dried, thenMATERIALS AND METHODS
redissolved in 25 ml of ethyl acetate. The samples were
Cells and antibodies
spotted onto Silica Gel 60 thin layer chromatography
(TLC) plates (Cat. No. 5748; EM Science, Gibbstown, NJ)The cells used in this study, GRE (Bandyopadhyay et
al., 1995); HeLa-tk- and HeLa-E1A (Kalvakolanu et al., and resolved with a 95:5 (V:V) methanol:chloroform sol-
vent. The ratio of acetylated vs nonacetylated chloram-1991) were grown in Dulbecco’s modified Eagle medium
(DMEM) supplemented with 10% fetal bovine serum, 100 phenicol was determined with PhosphorImage scanning
(Molecular Dynamics).units/ml of penicillin, and 100 mg/ml of streptomycin (Gib-
coBRL). HeLa-tk- and HeLa-E1A cells were the gifts of
Northern analysisAlex Van der Eb (Sylvius Laboratories, University of
Leiden, The Netherlands). Anti-STAT1a antibodies were
RNA from HeLa-E1A and HeLa-tk- cells, either treated
the gift of Berlex or J. Haque and B. R. G. Williams (Haque
for 18 hr with 500 U/ml of IFN-g or untreated was pre-
et al., 1995) where noted. Anti-Jak-1 antibody was the gift
pared using RNazol B (Cat. No. CS-105, Teltest, INC.,
of A. Ziemiecki. Anti-p48 antibody was from Transduction Friendswood, TX) according to the manufacturer’s speci-
Labs (Lexington, KY). fication. Twenty micrograms of RNA was subjected to
denaturing electrophoresis on a 1% agarose gel con-Interferons
taining formaldehyde and then transferred to a Gene-
Recombinant human interferon-g was the kind gift of screen membrane (Cat. No. NEF-983, NEN Research
Genentech (South San Francisco, U.S.A.). Products, Boston, MA). The blot was hybridized at 657
according to the method of Church and Gilbert (Church
Plasmids and Gilbert, 1984).
E1A expression plasmids p12s.WT (243R E1A) and
ImmunofluorescencepLE13s (289R E1A) were the gift of E. Moran (Wang et
al., 1993). The reporter constructs IRF-1 luciferase and Immunofluorescence was performed as described
GAS-tk-CAT were the generous gifts of J. Haque and B. previously (Shuai et al., 1992). The anti-STAT1a antibody
R. G. Williams. IRF-1 luciferase contains base pairs used was from J. Haque and B. R. G. Williams. Briefly,01312 to /7 of the IRF-1 gene cloned into a luciferase HeLa-tk- and HeLa-E1A cells were seeded onto cover
expression plasmid as previously reported (Haque et al., slips in 6-well plates. The cells were then treated for 15
1995). GAS-tk-CAT was made by cloning two copies of min with 100 U/ml IFN-g. The cells on the cover slips
the region from 0129 to 0106 of the IRF-1 gene con- were washed twice with 11 PBS then fixed for 2 min
taining the GAS element into a CAT expression vector with 1:1 methanol:acetone. The fixed cells were washed
driven by a minimal thymidine kinase (tk) promoter (bp twice with 11 TBST (10 mM Tris, pH 8; 150 mM NaCl;0109 to /51 of tk promoter) (Luckow and Schutz, 1987). 0.02% Tween 20) and then blocked with 3% bovine serum
All plasmid DNAs were prepared using Qiagen columns albumin in 11 TBST at room temperature for 40 min.
(Qiagen, Inc.). After brief washing the cells were incubated with 1:500
anti-STAT1a antibody in blocking solution for 2 hr. The
Transfection
cells were washed again and then incubated in the dark
with goat anti-rabbit-FITC-conjugated antibody (Cat. No.Equal amounts (10 mg each) of reporter construct (IRF-
1 luciferase or GAS-tk-CAT) and either E1A or pUC18 9817SA, GibcoBRL) for 70 min. The stained cells were
washed three more times with 11 TBST then mountedwere cotransfected into GRE cells using the calcium
phosphate method. Twenty hours later the precipitate on glass slides with one drop of Vectashield (Vector Lab-
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oratories) and photographed at 4001 magnification un- proper immunoprecipitation the blot was stripped for 30
min at 507 in 100 mM 2-mercaptoethanol, 2% SDS, 62.5der fluorescent excitement.
mM Tris/Cl, pH 6.8, then reblocked and probed with the
GAS electrophoretic mobility shift assay (EMSA) anti-STAT1a antibody (Berlex).
The GAS probe was made by annealing synthesized
Western blotsense 5*-gatcGCCTGATTTCCCCGAAATGACGGC-3* and
antisense 5*-gatcGCCGTCATTTCGGGGAAATCAGGC-3* For the STAT1a and Jak-1 immunoblots 20 mg of total
oligos from base pairs 0129 to 0106 of the IRF-1 gene. cellular extract prepared as described above for STAT1a
This annealed double-stranded probe was labeled by immunoprecipitation was subjected to denaturing elec-
using Klenow fragment and [a-32P]dCTP to fill in the ends. trophoresis then semi-dry blotted (TransBlot-SD, Bio-
Cells were treated for 15 min with 500 U/ml of IFN-g. Rad) onto PVDF membrane (Immobilon-P, Millipore). The
Preparation of extracts and EMSA were performed as membrane was blocked with 5% nonfat dry milk in 11
described previously (Haque and Williams, 1994). PyTBST buffer, then probed with the appropriate antibod-
ies (Anti-STAT1a from J. Haque and B. R. G. Williams).
Immunoprecipitation and antiphosphotyrosine For the p48 immunoblot 50 mg of whole cell extract pre-
Western blot pared was with a hypotonic buffer as described pre-
viously (Sadowski et al., 1993).HeLa-tk- and HeLa-E1A cells were treated for 15 min
with 500 U/ml of IFN-g. The cells were washed twice with
RESULTS11 PBS, scraped, then pelleted. The cells were lysed in
11 lysis buffer (0.5% NP-40, 50 mM Tris/Cl, pH 8.0, 10% Inhibition of IFN-g-inducible gene expression by
glycerol, 0.1 mM EDTA, 300 mM NaCl, 0.1 mM sodium adenovirus E1A protein
orthovanadate, 1 mM DTT, 0.4 mM PMSF, 5 mg/ml aproti-
nin, 2.5 mg/ml pepstatin, and 1 mg/ml leupeptin) for 1 hr We used two experimental approaches to examine the
effects of E1A on gene induction by IFN-g. For theseon ice. One milligram of extract protein from each sample
(as determined by the Bradford assay for protein (Bio- studies, the IRF-1 gene was used as the representative
IFN-g-inducible gene. This gene contains a GAS ele-Rad)) was precleared with 1:100 rabbit preimmune serum
in the presence of 1:10 protein A– Sepharose CL-4B (Cat. ment, and its induction by IFN-g is known to be mediated
by the trans-acting factor GAF (Sims et al., 1993; HaqueNo. 17-0780-01, Pharmacia, Sweden) for 60 min at 47
on a rotating wheel. The cleared supernatant was then and Williams, 1994). In the first set of experiments an
E1A-expression vector was cotransfected into a humanincubated with 1:167 rabbit anti-human STAT1a antibody
(Berlex) in the presence of 1:10 protein A– Sepharose glioblastoma cell line (GRE) with IFN-g-inducible reporter
genes. The transfected cells were treated with IFN-g,CL-4B overnight at 47 on a rotating wheel. The immuno-
precipitated complex was centrifuged and then washed and the levels of reporter gene expression were mea-
sured. A luciferase reporter gene driven by the transcrip-three times with 11 lysis buffer and one time with 11
PBS / 0.4 mM PMSF prior to boiling for 5 min in SDS- tional regulatory region of the IRF-1 gene (01312 to /7)
was used in the experiment shown in Fig. 1A. Luciferasecontaining gel loading dye. The samples were subjected
to denaturing gel electrophoresis through a 7.5% poly- activity was at a low level in the untreated cells, but as
expected, the level of activity was boosted 10-fold uponacrylamide gel. Protein was transferred to PVDF mem-
brane (Immobilon-P, Millipore) using a semi-dry blotter IFN-g treatment. When an expression vector for the E1A
243R protein was cotransfected with the reporter gene,(TransBlot-SD, Bio-Rad). The membrane was blocked
with 5% bovine serum albumin (Fraction V, 96-99% albu- the induction by IFN-g was greatly diminished. Similar
results were obtained when the IRF-1 luciferase vectormin, Cat. No. A-3350, Sigma, St. Louis) in 11 PyTBST (10
mM Tris – Cl, pH 7.4; 75 mM NaCl; 1 mM EDTA; 0.1% was cotransfected with an expression vector for the E1A
289R protein (Fig. 1B). A CAT reporter gene constructTween 20) buffer. The blot was probed with 1:1000
mouse anti-human phosphotyrosine monoclonal anti- driven by the thymidine kinase promoter and two GAS
elements derived from the IRF-1 gene was used for thebody (PY20, Cat. No. P11120, Transduction Laboratories,
Lexington, KY). After three subsequent 15-min washes experiment in Fig. 1C. Again, the expression of the GAS-
tk-CAT gene was also highly induced by IFN-g and thewith 11 PyTBST the blot was probed with 1:3000 second-
ary HRP-conjugated goat anti-mouse IgG antibody (Cat. E1A 243R protein blocked this induction completely.
These results demonstrated that the E1A 243R proteinNo. 605-250, Boehringer Mannheim) for 1 hr at room
temperature. The blot was washed four times for 15 min can efficiently block GAS-mediated induction of reporter
genes by IFN-g.each with 11 PyTBST and finally one time with 11 PyTBS
(10 mM Tris– Cl, pH 7.4; 75 mM NaCl; 1 mM EDTA). The In the second approach, we asked if the above conclu-
sion drawn from the cotransfection experiments alsocomplexes were examined with an epichemilumines-
cence kit from Amersham (Cat. No. RPN 2109). To detect holds for the resident cellular IRF-1 gene. For this pur-
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FIG. 2. A HeLa-derived cell line expressing E1A does not respond
to IFN-g with induction of IRF-1 mRNA. Northern blot of 20 mg cyto-
plasmic RNA from lane 1 — HeLa-tk untreated. Lane 2, HeLa-tk treated
for 18 hr with 500 U/ml of IFN-g. Lane 3, HeLa-E1A untreated. Lane 4,
HeLa-E1A treated for 18 hr with 500 U/ml of IFN-g. The blot was probed
with a random-primer-labeled IRF-1 cDNA.
pose, a HeLa cell line expressing the adenovirus 289R
protein was used. The same cell line has been previously
used by us to demonstrate that E1A can block IFN-a
signaling (Kalvakolanu et al., 1991). The E1A-expressing
cell line and the corresponding control cell line, HeLa-
tk-, were treated with IFN-g and the induction of IRF-1
mRNA was monitored by Northern blot analysis. As
shown in Fig. 2, IFN-g efficiently induced IRF-1 mRNA in
the control cells, but not in the E1A-expressing cells.
Thus, the results of the cotransfection experiments were
completely corroborated.
Block of GAF activation by E1A
IFN-g treatment of cells causes immediate activation
of the trans-acting factor, GAF (Shuai et al., 1992). Once
activated, GAF translocates from the cytoplasm to the
nucleus, binds to the GAS elements of the IFN-g-induc-
ible genes, and activates their transcription (Shuai et
al., 1993, 1992). Since we observed that IFN-g-mediated
induction of transcription was blocked in the E1A-ex-
pressing cells, we wondered whether it was due to a
block in GAF activation. To test this hypothesis, two ex-
periments were done to measure GAF activation. The
presence of activated GAF in the nuclei of E1A-express-
ing and control cells was monitored by immunofluores-
cence (Fig. 3) using an antibody to the STAT1a protein.
The signal was diffused in the cytoplasm of the control
cells (Fig. 3a), but upon IFN-g treatment for 15 min, it
FIG. 1. (A) Cotransfection of a 243R E1A expression construct with efficiently translocated to the nuclei (Fig. 3b). The un-
IRF-1 luciferase results in repression of IFN-g-inducible reporter ex- treated E1A-expressing cells also had a diffused signal
pression. GRE Cells were transfected with IRF-1 luciferase and either in the cytoplasm (Fig. 3c). However, in contrast to the
pUC18 or a 243R E1A expression construct then either left untreated
control cells, upon IFN-g treatment of the E1A-express-or treated with 500 U/ml of IFN-g. The extracts were tested for lucifer-
ing cells, the signal did not translocate to the nucleusase activity according to the manufacturer’s suggestion (Promega). (B)
Cotransfection of a 289R E1A expression construct with IRF-1 luciferase (Fig. 3d), suggesting the absence of GAF activation in
results in repression of IFN-g-inducible reporter expression. GRE cells these cells. Although it appears that IFN-g treatment re-
were transfected with IRF-1 luciferase and either pUC18 or an expres- duced the diffused signal present in the cytoplasm of the
sion construct for the 289 residue E1A protein (pLE13s). The cells were
E1A-expressing cells (Figs. 3c and 3d), this result waseither left untreated or treated with 500 U/ml of IFN-g. The extracts were
not reproducible and hence not analyzed further. Activa-tested for luciferase activity according to the manufacturer’s suggestion
(Promega). (C) Cotransfection of a 243R E1A expression construct with tion of GAF was also measured by the electrophoretic
GAS-tk-CAT results in downregulation of IFN-g-inducible reporter ex- mobility shift assay using the GAS element of the IRF-1
pression. GRE cells were transfected with a CAT construct driven by gene as the probe. Cells were treated with IFN-g for 15
a minimal tk promoter and two copies of IRF-1 GAS and either pUC18
min, and whole cell extracts were prepared. In the controlor a 243R E1A expression construct. The cells were either untreated
cells, IFN-g caused efficient activation of GAF, but noor treated with 500 U/ml of IFN-g. Extracts were tested for CAT activity
as previously described. activated GAF complex could be detected in the extracts
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FIG. 3. STAT1a does not translocate to the nucleus in response to IFN-g in HeLa-E1A cells. Anti-STAT1a Immunofluorescence assay. (a) HeLa-
tk cells untreated. (b) HeLa-tk cells treated for 15 min with 500 U/ml of IFN-g. (c) HeLa-E1A cells untreated. (d) HeLa-E1A cells treated for 15 min
with 500 U/ml IFN-g.
of IFN-g-treated, E1A-expressing cells (Fig. 4). These re- blot was stripped of the anti-phosphotyrosine antibody
and reprobed with the STAT1a antibody, we observedsults clearly established that the effect of E1A was at a
stage prior to GAF activation. that the same amount of STAT1a protein was present in
treated and untreated control cells (Fig. 5B, lanes 1, 2),
but there was no detectable STAT1a protein in the E1A-Tyrosine phosphorylation of STAT1a
expressing cells (Fig. 5B, lanes 3, 4).
GAF activation by IFN-g is a consequence of tyrosine
Abundance of signaling proteinsphosphorylation of the STAT1a protein, the major (or
sole) component of GAF. In the next experiment, we ex- Given the lack of detectable STAT1a protein in the
anti-phosphotyrosine experiment we decided to directlyamined if this tyr-phosphorylation event occurred in the
E1A-expressing cells. Extracts were prepared from IFN- measure the levels of STAT1a. A Western blot of whole
cell extracts from the two cell lines was probed with ag-treated and untreated cells, STAT1a (Fig. 5) protein
was immunoprecipitated from these extracts and sub- more potent STAT1a antibody. As shown in Fig. 6B,
HeLa-E1A cells contained no detectable STAT1a. Therejected to Western analysis using an anti-phosphotyro-
sine antibody. In the control cells, IFN-g treatment was, however, a faint cross-reacting protein of slightly
lower mobility. In contrast, the level of JAK1, one of thecaused an immediate tyr-phosphorylation of the STAT1a
protein (Fig. 5, lane 2). Such a phosphorylation, however, tyrosine kinases required for STAT1a phosphorylation,
was comparable in the two cell lines (Fig. 6A). Thus, thedid not occur in the E1A-expressing cells (Fig. 5, lane
4). These results indicated that the lesion of the IFN-g- defect in the IFN-g-signaling pathway in E1A-expressing
cells could be traced to a lower abundance of the crucialsignaling pathway in the E1A expressing cells was at
the level of STAT1a phosphorylation. When the same trans-acting factor, STAT1a.
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FIG. 6. The levels of Jak-1 are equivalent in HeLa-tk- and HeLa-E1A.
STAT1a is undetectable in HeLa-E1A, but there is a faint lower-mobility,
cross-reacting species present. Western blot of lane 1, 20 mg of whole
cell extract from HeLa-tk cells; lane 2, 20 mg of whole cell extract from
HeLa-E1A cells. (A) Anti-Jak-1 antibody. (B) Anti-STAT1a antibody.
observed (Fig. 7). This protein was strongly induced by
IFN-g in the control cells (lane 3), but not in the E1A-
expressing cells (lane 4). More importantly, the level of
the p48 protein was undetectable in the untreated E1A-
expressing cells (lane 2), whereas the control cells con-
FIG. 4. HeLa-E1A cells do not activate GAF in response to IFN-g. stitutively expressed this protein (lane 1). Thus, the ob-
Electrophoretic mobility shift assay with a labeled IRF-1 GAS probe.
served defect in ISGF3g formation is due to a lowerLanes 1 and 2, whole cell extracts from HeLa-tk cells. Lanes 3 and 4,
abundance of the p48 protein in HeLa-E1A cells.whole cell extracts from HeLa-E1A cells. Lanes 1 and 3, untreated;
lanes 2 and 4, treated for 15 min with 500 U/ml IFN-g.
DISCUSSION
We and others have previously shown that adenovirusThe above observation can explain why the IFN-a sig-
E1A proteins can interfere with the IFN-a signaling path-naling pathway is also blocked in the HeLa-E1A cells. In
way that is mediated by ISRE elements (Ackrill et al.,our previous study, we observed that IFN-a fails to acti-
1991; Gutch and Reich, 1991; Kalvakolanu et al., 1991).vate ISGF3, the IFN-a signaling trans-acting factor, in
As a result, the IFN-a-inducible genes are not expressedHeLa-E1A cells (Kalvakolanu et al., 1991). Since STAT1a
in E1A-expressing IFN-a-treated cells. The E1A-medi-is also a constituent of ISGF3, a lower cellular abundance
ated block of IFN-a signaling is due to a failure in theof this protein is expected to impair the formation of
formation of the crucial trans-acting factor ISGF3. IFN-gactive ISGF3. ISGF3 is composed of three proteins, tyro-
signaling pathways do not use ISGF3, but they use somesine-phosphorylated STAT1a and STAT2 and the ISRE-
of the protein components of ISGF3. The pathways usedbinding protein p48. We have developed a functional
by the two types of IFNs also use a common tyrosinecomplementation assay for separately measuring the lev-
kinase, Jak-1. IFN-g uses multiple pathways to induceels of p48 (also called ISGF3g) and the two activated
the expression of different sets of genes. Ackrill et al.STAT proteins (also called ISGF3a). We have reported
have reported that E1A proteins can inhibit IFN-g signal-that in IFN-a-treated HeLa-E1A cells, both components
ing through ISRE and the cis-elements of the MHC Classof ISGF3, ISGF3a, and ISGF3g, are defective. The current
II gene promoter (Ackrill et al., 1991). A different IFN-gobservation of a lower abundance of the STAT1a protein
signaling pathway is mediated by the cis-element, GAS.could explain why the ISGF3a component would be de-
The mechanism of the latter pathway is much better un-fective, but additional reasons are required for explaining
derstood than the other IFN-g-signaling pathways, andthe observed ISGF3g defect. ISGF3g is composed of the
it is the only direct pathway which does not require ongo-p48 protein (Veals et al., 1992). It is present constitutively
ing protein synthesis. Here, we have shown that the E1Ain most cell lines and its level is elevated by IFN-g. When
proteins can also block IFN-g signaling through the GASwe examined the levels of the p48 protein in the HeLa-
element.tk- and the HeLa-E1A cells, a notable difference was
For studying the effects of E1A on IFN-g-mediated sig-
naling through GAS, we selected the IRF-1 gene whose
transcriptional regulation by IFN-g has been well studied
FIG. 5. STAT1a from HeLa-E1A cells is not tyrosine phosphorylated
in response to IFN-g. Anti-STAT1a immunoprecipitation from lanes 1 FIG. 7. The levels of p48 are much lower in HeLa-E1A cells than in
HeLa-tk- cells. Western blots of lanes 1 and 3, 50 mg of whole celland 2, whole cell extracts from HeLa-tk cells; lanes 3 and 4, extracts
from HeLa-E1A cells. Lanes 1 and 3, untreated; lanes 2 and 4, treated extract from HeLa-tk-cells. Lanes 2 and 4, 50 mg of whole cell extract
from HeLa-E1A cells. The extracts in lanes 1 and 2 are from untreatedfor 15 min with 500 U/ml IFN-g. (A) Anti-phosphotyrosine antibody
probe. (B) The same blot was stripped and reprobed with anti-STAT1a cells, the extracts in lanes 3 and 4 are from cells treated for 18 hr with
500 U/ml of IFN-g.antibody probe.
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FIG. 8. The sites for E1A-mediated blockades in (A) IFN-g and (B) IFN-a signaling pathways are shown. The various proteins that are affected
by E1A are crossed out. 561 is an IFN-a-inducible gene (Bandyopadhyay et al., 1995). IFNGR-1 and IFNGR-2 are the two known subunits of the
IFN-g–receptor complex; IFNAR-1 and IFNAR-2 are the two known subunits of the IFN-a–receptor complex. Other proteins in the diagrams are
described in the Introduction.
(Sims et al., 1993). Our results clearly showed that IFN- candidate is the dexamethasone-inducible E1A-express-
ing cell line established by Brunet and Berk (1988). How-g cannot induce the IRF-1 gene in E1A-expressing cells.
Moreover, the cotransfection experiments demonstrated ever, this line may not be suitable for analyzing IFN-
signaling, since glucocorticoids are known to affect genethat among the multiple cis-elements present in the regu-
latory region of this gene, it is the GAS element which induction by IFNs (Tanaka et al., 1996); we may have to
generate new cell lines expressing E1A regulated byfails to respond to IFN-g in cells expressing E1A. GAF,
the transcription factor which binds to the GAS element other inducible systems such as the tetracycline-respon-
sive promoter.has been extensively studied. It contains a dimer of the
protein STAT1a (Shuai et al., 1992). The dimerization of Although E1A blocked both IFN-g-mediated transcrip-
tional induction of the IRF-1 gene and expression of theSTAT1a and the concomitant translocation of the protein
from the cytoplasm to the nucleus depend on its tyrosine transiently transfected IRF-1 promoter driven reporter
genes, the underlying mechanisms of the two types ofphosphorylation (Shuai et al., 1993) (Fig. 8A). Our results
show that none of these events occurs in the IFN-g- inhibition may not be the same. Since in the transient
transfection protocol only a small number of cells in thetreated E1A-expressing cells. The reason for these de-
fects is the absence of a detectable level of STAT1a population expresses the transfected DNA, we could not
directly determine whether the transiently expressed E1Aprotein in these cells. The level of the IFN-g-signal-medi-
ating tyrosine kinase Jak1 was, however, not diminished. could affect the level of the STAT1 protein. Shortening
the time interval between the transfection and the begin-Further studies will be required to delineate the level of
down regulation of STAT1a protein in the E1A-expressing ning of IFN-g treatment did not diminish the observed
inhibition. When IFN treatment was started after only 4,cells. A block in the corresponding mRNA or protein syn-
thesis or an enhanced degradation of either molecule or 8, or 12 hr after transfection, E1A could still inhibit IRF-
1 luciferase expression (data not shown). An 18-hr treat-a combination thereof may cause a decreased cellular
level of the STAT1a protein. It also remains unclear how ment time, however, was needed for the IFN-g treatment.
Thus, the minimum time to which the transfected cellsE1A causes this effect or whether E1A functions directly
or indirectly to decrease STAT1a protein. Appropriate were potentially exposed to E1A was 22 hr. If this length
of time is sufficient for lowering the cellular level ofcell lines expressing E1A in an inducible fashion will be
required for answering these questions. One potential STAT1, the mechanisms of inhibition by the transiently
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